Bluebird Bio (BLUE)
5.23 +1.15 (+28.19%) 11:45 ET [NASDAQ]
5.20 x 100 5.26 x 100
Realtime by (Cboe BZX)
5.20 x 100 5.26 x 100
Realtime 4.44 +0.36 (+8.82%) 09:30 ET
for Mon, Mar 31st, 2025
Results
download Want to compare other data? Select Fields| Symbol | BLUE | AGEN | LTRN | ||
| Company | Bluebird Bio | Agenus Inc | Lantern Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.43 | 1.5600 | 3.50 | ||
| High | 5.42 | 1.5700 | 3.54 | ||
| Low | 4.41 | 1.5000 | 3.40 | ||
| Last | 5.23 | 1.5000 | 3.41 | ||
| Change | +1.15 | -0.1000 | -0.14 | ||
| % Change | +28.19% | -6.25% | -3.98% | ||
| Volume | 2,502,465 | 132,852 | 10,786 | ||
| 20-Day Average Volume | 402,171 | 474,343 | 27,259 | ||
| Previous Close | 4.08 | 1.6000 | 3.55 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.97 | 1.8775 | 3.74 | ||
| 20-Day Raw Stochastic | 98.05% | 0.00% | 11.20% | ||
| 20-Day Relative Strength | 52.87% | 26.67% | 41.33% | ||
| Weighted Alpha | -65.83 | -82.35 | -60.55 | ||
| Today's Opinion | 80% Sell | 100% Sell | 56% Sell | ||
| Previous Opinion | 88% Sell | 100% Sell | 56% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +31.63% since 03/24/25 | -8.54% since 03/24/25 | -11.07% since 03/24/25 | ||
| Low | 3.65 on 03/27/25 | 1.5000 on 03/31/25 | 3.40 on 03/31/25 | ||
| High | 5.19 on 03/31/25 | 1.7650 on 03/27/25 | 4.00 on 03/26/25 | ||
| 1-Month | |||||
| %Chg | +26.47% since 02/28/25 | -47.37% since 02/28/25 | -12.19% since 02/28/25 | ||
| Low | 3.65 on 03/27/25 | 1.5000 on 03/31/25 | 3.40 on 03/11/25 | ||
| High | 5.19 on 03/31/25 | 2.9000 on 03/03/25 | 4.01 on 03/24/25 | ||
| 3-Month | |||||
| %Chg | -41.23% since 12/27/24 | -45.45% since 12/27/24 | +1.41% since 12/27/24 | ||
| Low | 3.56 on 02/24/25 | 1.5000 on 03/31/25 | 2.95 on 12/31/24 | ||
| High | 10.28 on 01/06/25 | 4.1500 on 01/22/25 | 6.12 on 01/24/25 | ||
| 6-Month | |||||
| %Chg | -48.85% since 09/27/24 | -71.75% since 09/27/24 | -8.12% since 09/27/24 | ||
| Low | 3.56 on 02/24/25 | 1.5000 on 03/31/25 | 2.79 on 11/21/24 | ||
| High | 15.40 on 12/04/24 | 5.8100 on 09/30/24 | 6.12 on 01/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 39,667 | 40,494 | 38,287 | ||
| Shares Outstanding, K | 9,722 | 25,309 | 10,785 | ||
| Annual Sales | 29,500,000 | 103,460,000 | 0 | ||
| Annual Net Income | -211,910,000 | -227,210,000 | -15,960,000 | ||
| Last Quarter Sales | 10,610,000 | 26,840,000 | 0 | ||
| Last Quarter Net Income | -60,810,000 | -45,860,000 | -4,510,000 | ||
| 60-Month Beta | 0.76 | 1.23 | 1.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -6.20 on 11/14/24 | -2.04 on 03/11/25 | -0.42 on 11/07/24 | ||
| Latest Earnings Date | 11/19/24 | 05/06/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||